KCT0009573
Not yet recruiting
未知
Randomized, double-blinded, crossover clinical trial comparing characteristics and satisfaction of single-implant prostheses fabricated with multi-layer zirconia block
Yonsei University Health System, Dental Hospital0 sites26 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Yonsei University Health System, Dental Hospital
- Enrollment
- 26
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •· Individuals aged 19 years or older
- •· Those requiring a single\-implant prosthesis in the maxillary or mandibular anterior and first premolar regions
- •· Individuals who have signed the clinical trial consent form
Exclusion Criteria
- •· Individuals who cannot read the consent form
- •· Individuals without adjacent teeth in the area where the single\-implant prosthesis will be placed
- •· Individuals with uncontrolled systemic diseases
- •· Individuals with hypersensitivity to titanium or zirconia materials
- •· Individuals whose participation is deemed inappropriate by the principal research investigator due to clinically significant medical findings
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Double-blind, randomized, controlled, clinical trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19COVID-related Acute Respiratory Distress SyndromeMedDRA version: 21.1Level: PTClassification code 10001052Term: Acute respiratory distress syndromeSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 23.0Level: PTClassification code 10084268Term: COVID-19System Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2020-002193-27-ESCristina Avendano-Sola20
Active, not recruiting
Phase 1
Clinical trial to evaluate and compare the efficacy and safety of Hemorrane® PlusEUCTR2019-003024-20-ESFAES FARMA SA185
Active, not recruiting
Phase 1
Clinical trial to evaluate if treatment with calcifediol (vitamin D analog) reduces the number of hospital admissions in patients with COVID-19.EUCTR2021-000316-31-ESFAES FARMA S.A.804
Active, not recruiting
Phase 1
Study to compare the clinical and radiological efficacy of 625 mg vs 1250 mg of oral methylprednisolone in patients with multiple sclerosis in relapse.Multiple sclerosisMedDRA version: 15.0Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2012-001965-34-ESServicio de Neurología, HU. Germans Trias i Pujol
Active, not recruiting
Phase 1
clinical trial or the anti-inflammatory effects of Curazink for 8 weeks in elderly patients with mild cognitive impairment in Alzheimer's disease or in patients with mild Alzheimer's diseaseIncluded are patients with the presence of a moderate or pronounced zinc deficienc and the diagnosis of a mild cognitive disorder, which may be due to an additional investigation (amyloid PET and / or cerebrospinal fluid) in the context of already performed diagnostic clarification an Alzheimer's pathology.Therapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2018-000342-19-DEOtto-von-Guericke-Universität Magdeburg, Medizinische Fakultät40